🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Status
Active Not Recruiting
Location
University of California, San Diego
Start Date
2025-01-03
Trial ID
NCT06710223
Treatments Being Tested
The treatment options for unresectable HCC have rapidly developed, and immu...
Status
Unknown
Location
Hunan Provincial People's Hospital(The First Affiliated Hospital of Hunan Normal University)
Start Date
2024-03-03
Trial ID
NCT06364007
Treatments Being Tested
Several cancer immunotherapies that target the PD-L1/PD-1 pathway (i.e., ch...
Status
Recruiting
Location
CHU de Besançon
Start Date
2025-06-25
Trial ID
NCT06796114
Treatments Being Tested
The purpose of this study is to test the safety and efficacy of an investig...
Status
Withdrawn
Location
Case Comprehensive Cancer Center Cleveland Clinic Taussig Cancer Center
Start Date
2025-11
Trial ID
NCT06608940
Treatments Being Tested
Given the number of anticipated durvalumab-based treatment launches in the ...
Status
Recruiting
Location
Research Site
Start Date
2023-12-19
Trial ID
NCT06252753
This is a single-arm, phase II study of patients with advanced liver cancer...
Status
Recruiting
Location
UT Health San Antonio
Start Date
2024-12-02
Trial ID
NCT06526104
Treatments Being Tested
This is an early-phase study testing a new combination treatment for cancer...
Status
Withdrawn
Location
New York-Presbyterian Weill Cornell Medical College
Start Date
2025-10-01
Trial ID
NCT06994299
Treatments Being Tested
The investigators are doing this study to learn if a combination of immunot...
Status
Recruiting
Location
Cedars Sinai
Start Date
2026-04-01
Trial ID
NCT07489976
RBS2418 is a targeted immune modulator that inhibits ectonucleotide pyropho...
Status
Recruiting
Location
Johns Hopkins
Start Date
2026-04-10
Trial ID
NCT07175441
Treatments Being Tested
This retrospective observational study compares two first-line immunotherap...
Status
Active Not Recruiting
Location
Sohag Oncology Center
Start Date
2026-03-01
Trial ID
NCT07669597